Advertisement

Mechanisms of Disease, Etiology and Clinical Manifestations

  • Michael BöhmigEmail author
Chapter

Abstract

Crohn’s disease and ulcerative colitis are inflammatory diseases without a single cause. A genetic predisposition and environmental risk factors contribute to developement of the disease.

IBD are caused by an inadequate response of the immune system to the normal, nonpathogenic intestinal bacteria resulting in intestinal damage. The gut microbiome of patients shows alterations. The intestinal barrier is impaired.

Environmental factors seem to play a variable role. Smoking has negative impact on Crohn’s disease.

UC is limited to the colon. CD may involve any part of the intestinal tract and is characterized by transmural inflammation, formation of stenoses, and fistulae.

While the bowel is the main place of manifestation, various other parts of the body may also be affected (extraintestinal manifestations, EIM).

Keywords

Genetic susceptibility Environmental factors Disruption of intestinal barrier Dysregulation of immune system Dysbiosis of microbiome Extraintestinal manifestations Fistula Stenoses 

References

  1. Baumgart DC, Carding SR (2007) Inflammatory bowel disease: cause and immunobiology. Lancet 369(9573):1627–1640CrossRefGoogle Scholar
  2. Baumgart DC, Sandborn WJ (2012) Crohn’s disease. Lancet 380:1590–1605CrossRefGoogle Scholar
  3. Ek W, D’Amato M, Halfvarson J (2014) The history of genetics in inflammatory bowel disease. Ann Gastroenterol 27(4):294–303PubMedPubMedCentralGoogle Scholar
  4. Gordon H, Moller FT, Andersen V, Harbord M (2015) Heritability in inflammatory bowel disease: from the first twin study to genome-wide association studies. Inflamm Bowel Dis 21(6):1428–1434PubMedPubMedCentralGoogle Scholar
  5. Kim ER, Chang DK (2014) Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis. World J Gastroenterol 20(29):9872–9881CrossRefGoogle Scholar
  6. Rieder F, Fiocchi C, Rogler G (2017) Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases. Gastroenterology 152(2):340–350CrossRefGoogle Scholar
  7. Scharl M, Rogler G (2014) Pathophysiology of fistula formation in Crohn’s disease. World J Gastrointest Pathophysiol 5(3):205–212CrossRefGoogle Scholar

Further Reading/Sources

  1. Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel J-F (2017) Ulcerative colitis. Lancet 389(10080):1756–1770CrossRefGoogle Scholar
  2. Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ (2012) Ulcerative colitis. Lancet 380(9853):1606–1619CrossRefGoogle Scholar
  3. Cleynen I, Boucher G (2016) Inherited determinants of Crohn’s disease and ulcerative colitis phenotypes: a genetic association study. Lancet 387(10014):156–167CrossRefGoogle Scholar
  4. Abraham C, Cho JH (2009) Inflammatory bowel disease. N Engl J Med 361:2066–2078CrossRefGoogle Scholar
  5. Klionsky DJ (2009) Crohn’s disease, autophagy, and the paneth cell. N Engl J Med 360:1785–1786CrossRefGoogle Scholar
  6. Torres J, Mehandru S, Colombel J-F, Peyrin-Biroulet L (2017) Crohn’s disease. Lancet 389(10080):1741–1755CrossRefGoogle Scholar
  7. Calvin Coffey J, Peter O’Leary D (2016) The mesentery: structure, function, and role in disease. Lancet Gastroenterol Hepatol 1(3):238–247CrossRefGoogle Scholar
  8. Silverberg MS, Satsangi J, Ahmad T et al (2005) Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19(Suppl A):5A–36ACrossRefGoogle Scholar
  9. Pariente B, Cosnes J, Danese S et al (2011) Development of the Crohn’s disease digestive damage score, the Lémann score. Inflamm Bowel Dis 17(6):1415–1422CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Medizinische Klinik (Gastroenterologie, Hepatologie, Onkologie, Infektiologie)Agaplesion Markus KrankenhausFrankfurt am MainGermany

Personalised recommendations